Abstract
Bone-marrow cells have the potential to differentiate into other cell types such as muscle fibres, and can be transplanted into acutely1 or chronically2 damaged muscle as a way of delivering normal dystrophin (the protein that is defective or missing in Duchenne's muscular dystrophy) to the skeletal and heart muscle of mdx mice2,3, an animal model for this disease. But the corrective potential of this approach has been hard to estimate against the high background of muscle fibres that spontaneously revert to synthesizing dystrophin, a feature of the original mdx mutation4. Here we test the long-term efficacy of bone-marrow transplantation in a different mdx mutant which is free of this problem and find that it has no impact on murine muscular dystrophy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ferrari, G. et al. Science 279, 1528–1530 (1998).
Gussoni, E. et al. Nature 401, 390–394 (1999).
Bittner, R. E. et al. Anat. Embryol. 199, 391–396 (1999).
Danko, I. et al. Pediatr. Res. 32, 128–131 (1992).
Emery, A. E. H. Duchenne Muscular Dystrophy 2nd edn (Oxford Univ. Press, Oxford, 1993).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferrari, G., Stornaiuolo, A. & Mavilio, F. Failure to correct murine muscular dystrophy. Nature 411, 1014–1015 (2001). https://doi.org/10.1038/35082631
Issue Date:
DOI: https://doi.org/10.1038/35082631
This article is cited by
-
The golden retriever model of Duchenne muscular dystrophy
Skeletal Muscle (2017)
-
Normal muscle regeneration requires tight control of muscle cell fusion by tetraspanins CD9 and CD81
Nature Communications (2013)
-
The Rag2–Il2rb–Dmd– Mouse: a Novel Dystrophic and Immunodeficient Model to Assess Innovating Therapeutic Strategies for Muscular Dystrophies
Molecular Therapy (2013)
-
Sources for skeletal muscle repair: from satellite cells to reprogramming
Journal of Cachexia, Sarcopenia and Muscle (2013)
-
Age-dependent alteration in muscle regeneration: the critical role of tissue niche
Biogerontology (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.